MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
90 hedge funds and large institutions have $98.4M invested in Marinus Pharmaceuticals, Inc in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 30
65% less capital invested
Capital invested by funds: $279M → $98.4M (-$180M)
Holders
90
Holding in Top 10
3
Calls
$6.41M
Puts
$2.13M
Top Buyers
| 1 | +$7.61M | |
| 2 | +$4.88M | |
| 3 | +$4.59M | |
| 4 |
Goldman Sachs
New York
|
+$4.21M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$3.06M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$9.08M | |
| 3 | -$4.09M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.59M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3M |